China SXT Pharmaceuticals, Inc.
SXTC
$0.09
-$0.01-5.62%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -693.52% | -693.52% | -137.91% | -137.91% | 91.72% |
| Total Depreciation and Amortization | -53.06% | -53.06% | -86.25% | -86.25% | -33.27% |
| Total Amortization of Deferred Charges | -- | -- | 440.50% | 440.50% | -58.46% |
| Total Other Non-Cash Items | 15,924.71% | 15,924.71% | 117.39% | 117.39% | -99.59% |
| Change in Net Operating Assets | -32.98% | -32.98% | 67.68% | 67.68% | -336.35% |
| Cash from Operations | -29.13% | -29.13% | 26.71% | 26.71% | -134.16% |
| Capital Expenditure | -- | -- | 71.43% | 71.43% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2,377.34% | -2,377.34% | 238.24% | 238.24% | 107.14% |
| Total Debt Issued | -95.84% | -95.84% | -77.46% | -77.46% | 5,815.87% |
| Total Debt Repaid | -47.57% | -47.57% | -419.85% | -419.85% | 98.30% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 38.77% | 38.77% | -- |
| Cash from Financing | -25.79% | -25.79% | -36.76% | -36.76% | 262.20% |
| Foreign Exchange rate Adjustments | -27.34% | -27.34% | -597.60% | -597.60% | 158.40% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -52.33% | -52.33% | -162.63% | -162.63% | 209.02% |